Voted as the #1 Most Influential Physician Executive in the United States in 2012 in a national poll conducted by Modern Healthcare, Dr. Topol works on genomic and wireless digital innovative technologies to reshape the future of medicine.
He is a practicing cardiologist at Scripps in La Jolla, California and widely credited for leading the Cleveland Clinic to become the #1 center for heart care. While there he also started a new medical school, led many worldwide clinical trials to advance care for patients with heart disease, and spearheaded the discovery of multiple genes that increase susceptibility for heart attacks. Since 2006, in La Jolla, he leads the flagship NIH supported Scripps Translational Science Institute and is a co-Founder of the West Wireless Health Institute. He also serves as Professor of Genomics at The Scripps Research Institute and Chief Academic Officer of Scripps Health.
Topol pioneered the development of many medications that are routinely used in medical practice including t-PA, Plavix, Angiomax, and ReoPro and was the first physician to raise safety concerns on Vioxx. He has published 1100 peer-reviewed articles and over 30 medical textbooks. In 2009, along with Francis Collins and Harold Varmus, Topol was selected to be one of the country’s 12 “Rock Stars of Science” in GQ Magazine. In 2011, the University of Michigan, where he had served on the faculty, initiated the Eric Topol Professor of Cardiovascular Medicine to recognize his contributions. The University of Rochester, his alma mater medical school, awarded him the Hutchinson Medal, the University’s highest honor. He was elected to the Institute of Medicine of the National Academy of Sciences and is one of the top 10 most cited researchers in medicine. His book The Creative Destruction of Medicine (Basic Books) was published in 2012. In 2013, he additionally took on the Editor-in-Chief role at Medscape.
Board of Directors: Dexcom, Sotera Wireless, Volcano. Scientific Advisory Boards: Gilead Sciences, Inc., Biological Dynamics, Portola Pharmaceuticals, AltheaDX, Genapsys. Consultant/Advisor: Cypher Genomics (Co-Founder), Quest Diagnostics. Editor-in-Chief: Medscape (WebMD). Research Funding Sources: National Institutes of Health, Qualcomm Foundation.
Nicholas J. Schork, Ph.D., is Director of Bioinformatics and Biostatistics at STSI and Professor, Department of Molecular and Experimental Medicine at TSRI.
His interest and expertise are quantitative human genetics and genomics, especially the design and implementation of methodologies to dissect the genetic basis of complex traits and diseases. He has published over 250 scientific articles and book chapters on the analysis of complex, multi-factorial traits and diseases.
Prior to joining Scripps in 2007, he served for seven years as Professor of Biostatistics and Psychiatry, and Co-Director of the Center for Human Genetics and Genomics at the UC San Diego. From 1994 to 2000, he was an Associate Professor of Epidemiology and Biostatistics at Case Western Reserve University in Cleveland, Ohio, and an Associate Professor of Biostatistics at Harvard University.
During 1999 and 2000, he took a leave of absence to conduct research as the Vice President of Statistical Genomics at the French biotechnology company, Genset, where he helped guide efforts to construct the first high-density map of the human genome.
A member of several scientific journal editorial boards, Nik is a frequent participant in U.S. National Institutes of Health-related steering committees and review boards, and has served on the advisory board of five companies.
In addition, he is currently Director of the Bioinformatics and Biostatistics Core of the National Institute of Aging- sponsored Longevity Consortium and a member of the Genetic Association Information Network (GAIN) data analysis committee of the National Human Genome Research Institute
Nik earned the B.A. in Philosophy, M.A. in Philosophy, M.A. in Statistics, and Ph.D., in Epidemiology, all at the University of Michigan in Ann Arbor.